Valuation: Ono Pharmaceutical Co., Ltd.

Market Cap 1,169B 7.31B 6.61B 6.1B 5.52B 10.42B 687B 10.73B 73.21B 29.09B 367B 27.42B 26.84B P/E 2027 *
15.6x
P/E 2028 * 18.2x
Enterprise Value 967B 6.04B 5.47B 5.05B 4.57B 8.62B 568B 8.88B 60.56B 24.07B 304B 22.69B 22.2B EV / Sales 2027 *
2.09x
EV / Sales 2028 * 2.04x
Free-Float
82.24%
Yield 2027 *
3.22%
Yield 2028 * 3.22%
1 day-0.52%
1 week+5.14%
Current month+9.64%
1 month+7.68%
3 months+2.32%
6 months-3.11%
Current year+13.86%
1 week 2,379
Extreme 2379
2,497.5
1 month 2,111.5
Extreme 2111.5
2,565.5
Current year 2,111.5
Extreme 2111.5
2,674.5
1 year 1,988
Extreme 1988
2,674.5
3 years 1,474
Extreme 1474
2,849
5 years 1,474
Extreme 1474
3,990
10 years 1,474
Extreme 1474
3,990
Manager TitleAgeSince
Chief Executive Officer 68 01/04/2024
Director of Finance/CFO - 01/04/2026
President 57 01/04/2024
Director TitleAgeSince
Chairman 68 01/04/2024
Director/Board Member 57 01/06/2020
Director/Board Member 77 26/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%+5.14%+23.43%-6.85% 7.13B
-0.70%+4.58%+40.23%+138.79% 1,280B
+1.11%+4.11%+45.85%+92.54% 675B
-0.18%+2.15%+26.25%+112.46% 521B
+1.14%+3.78%+39.98%+71.70% 386B
-0.16%+0.01%+60.69%+44.94% 363B
+1.11%+0.07%+28.19%+60.05% 301B
+0.24%-0.80%+3.05%+38.06% 286B
-0.22%+1.47%+38.89%+74.73% 253B
-1.05%+0.23%+36.10%+121.22% 211B
Average +0.08%+0.40%+34.27%+74.76% 428B
Weighted average by Cap. +0.06%+0.57%+37.48%+97.15%

Financials

2027 *2028 *
Net sales 463B 2.89B 2.61B 2.41B 2.18B 4.12B 272B 4.25B 28.97B 11.51B 145B 10.85B 10.62B 449B 2.81B 2.54B 2.34B 2.12B 4B 264B 4.12B 28.11B 11.17B 141B 10.53B 10.31B
Net income 75.38B 471M 426M 393M 356M 672M 44.3B 692M 4.72B 1.88B 23.68B 1.77B 1.73B 64.18B 401M 363M 335M 303M 572M 37.71B 589M 4.02B 1.6B 20.16B 1.51B 1.47B
Net Debt -202B -1.26B -1.14B -1.05B -954M -1.8B -119B -1.85B -12.65B -5.03B -63.44B -4.74B -4.64B -251B -1.57B -1.42B -1.31B -1.19B -2.24B -148B -2.31B -15.73B -6.25B -78.93B -5.89B -5.77B
Projected Income Statement - Annual - Ono Pharmaceutical Co., Ltd.
Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Employees
4,206
Date Price Change Volume
13/11/26 ¥2,473.50 -0.52% 538,400
12/11/26 ¥2,486.50 +2.58% 1,332,500
11/11/26 ¥2,424.00 -0.90% 1,206,300
10/11/26 ¥2,446.00 +0.55% 1,603,800
09/11/26 ¥2,432.50 +3.40% 1,497,600
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Ono Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,486.50JPY
Average target price
2,512.50JPY
Spread / Average Target
+1.05%
  1. Stock Market
  2. Stocks
  3. 4528 Stock